Blockchain Registration Transaction Record
Theriva Biologics Receives FDA Fast Track Designation for VCN-01 in Pancreatic Cancer Treatment
Theriva Biologics receives FDA Fast Track Designation for VCN-01, a promising treatment for pancreatic cancer. This milestone underscores the potential to improve patient outcomes and reduce mortality. Learn more about the company's innovative approach to cancer treatment.
![Theriva Biologics Receives FDA Fast Track Designation for VCN-01 in Pancreatic Cancer Treatment](/_next/image?url=https%3A%2F%2Fpublic.newsdirect.com%2F427600911%2FWwIT4Dxn.png&w=640&q=75)
The FDA's Fast Track Designation for VCN-01 reflects the urgent need for new treatment options for pancreatic cancer, a leading cause of cancer death globally. This milestone underscores the potential of VCN-01 to improve patient outcomes and reduce mortality. As incidences of pancreatic cancer continue to rise, Theriva Biologics' focus on innovative cancer therapies could have a significant impact on the industry and patient care.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xab06457955e387febce8a8fcff2656542ce337e9ac7935188140d4784bc4901f |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | mask2HNw-9feae1f955303b28167d3ef10016997a |